0001453687-22-000025.txt : 20220105 0001453687-22-000025.hdr.sgml : 20220105 20220105163630 ACCESSION NUMBER: 0001453687-22-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TRABER PETER G CENTRAL INDEX KEY: 0001284500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37798 FILM NUMBER: 22511686 MAIL ADDRESS: STREET 1: 430 THAMER LANE CITY: HOUSTON STATE: TX ZIP: 77025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SELECTA BIOSCIENCES INC CENTRAL INDEX KEY: 0001453687 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 GROVE STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-923-1400 MAIL ADDRESS: STREET 1: 65 GROVE STREET CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 wf-form4_164141856949283.xml FORM 4 X0306 4 2022-01-03 0 0001453687 SELECTA BIOSCIENCES INC SELB 0001284500 TRABER PETER G C/O SELECTA BIOSCIENCES, INC. 65 GROVE STREET WATERTOWN MA 02472 0 1 0 0 Chief Medical Officer Common Stock 2022-01-03 4 A 0 90200 0 A 254581 D Employee Stock Option (right to buy) 3.31 2022-01-03 4 A 0 415900 0 A 2032-01-02 Common Stock 415900.0 415900 D Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 3, 2023. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 3, 2026. This option vests as to 25% on January 3, 2023. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter. /s/ Matthew Bartholomae, Attorney-in-Fact for Peter G. Traber 2022-01-05